Print this page    •   Back to Web version of article

International News
Malawi, Zimbabwe May Struggle to Implement WHO HIV/AIDS Treatment Guidelines

July 12, 2010

Inter Press Service examines the growing concern among HIV/AIDS advocates that the Malawian government's adoption of the WHO's updated HIV/AIDS treatment guidelines will lead to a decrease in the number of HIV-positive patients with access to free treatment. Malawi "has been procuring the first line of the HIV course of therapy ... at about 33 dollars but the new drugs will cost the government 100 dollars per month for every person, according to [Mary Shawa,] Principal Secretary for HIV and AIDS in the office of the president and cabinet," the news service writes. "Currently the Malawi government provides free anti-retroviral drugs to about 250,000 people. There are up to one million people living with HIV and the HIV prevalence rate is at 12 percent, according to the Ministry of Health," IPS adds (Ngozo, 7/10).

In related news, Agence France-Presse reports that Zimbabwe "may not have enough anti-AIDS drugs to comply with [WHO] recommendations on providing treatment to people with HIV. … 'The number of people in need of treatment will double if we follow the World Health Organisation plan,' Tsitsi Mutasa Apollo, co-ordinator of HIV treatment in the health ministry, said" in a state-run newspaper on Sunday." According to Zimbabwean publication, "The new guidelines would mean about 500,000 people need treatment," AFP adds (7/11).

Back to other news for July 2010

This information was reprinted from with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.